Summary:
The purpose of this clinical research study is to learn more about the use of the study medication, BNC210, which is being developed for the treatment of PTSD. In this study, the study medication will be compared to a placebo. You will receive either BNC210 or placebo. Whether you receive BNC210 or placebo will be decided randomly.
You may qualify for the PTSD Study if you: Are between the ages of 18 and 65 and have a current diagnosis of PTSD. The trauma event must have occurred in adulthood, i.e., when the participant was ≥18 years of age.
Qualified Participants May Receive:
If you qualify, you may receive investigational medication and study-related procedures from a local doctor. Reimbursement for time and travel related to study participation may be provided.